Therefore, the two common MEF2D fusion BCP-ALL subtype variants should share similarity in terms of hyperactivated PI3K/AKT, HDAC, MAPK signaling pathways, and BCL2 family. This evidence concerns the gene HDAC9 and acute lymphoblastic leukemia.